Amorfix presents scientific update for its Alzheimer's disease diagnostic at Alzheimer's disease conference
CNW Group - Thu Jul 17, 7:15AM CDT
TSX: AMF
Amorfix awarded broad United States patent for misfolded SOD1-targeted treatment of ALS
CNW Group - Wed Jul 16, 7:15AM CDT
TSX: AMF
Amorfix announces fiscal 2014 year end results
CNW Group - Fri Jun 13, 5:00PM CDT
TSX: AMF
William Wyman appointed Amorfix Chairman of the Board
CNW Group - Thu Jun 12, 6:30AM CDT
TSX: AMF
Former Amorfix Board member Walter Von Wartburg to act as Board advisor
CNW Group - Thu Mar 20, 6:30AM CDT
TSX: AMF
Amorfix and Trellis Bioscience to collaborate on anti-CD38 antibody treatment for cancer
CNW Group - Mon Mar 17, 7:00AM CDT
TSX: AMF
Amorfix appoints Mr. William Wyman and Mr. William Copeland to Board Of Directors
CNW Group - Wed Mar 12, 7:15AM CDT
TSX: AMF
Amorfix Chief Scientific Officer leads the way for ALS research
CNW Group - Thu Feb 20, 7:00AM CST
TSX: AMF
Amorfix announces fiscal 2014 third quarter results
CNW Group - Thu Feb 13, 6:30PM CST
TSX: AMF
Amorfix Announces Retirement of Walter von Wartburg
CNW Group - Fri Jan 24, 6:00PM CST
TSX: AMF
IIROC Trade Resumption - AMF
CNW Group - Wed Jan 22, 8:07AM CST
Trading resumes in:
IIROC Trading Halt - AMF
CNW Group - Wed Jan 22, 7:35AM CST
The following issues have been halted by IIROC:
Amorfix enters into agreement with a major global pharmaceutical company for Alzheimer's disease diagnostic
CNW Group - Wed Jan 22, 7:30AM CST
TSX: AMF
Amorfix Reports Update on Lead Ovarian Cancer Program
CNW Group - Wed Aug 14, 7:00AM CDT
TSX: AMF
Amorfix Announces Fiscal 2014 First Quarter Results
CNW Group - Tue Aug 13, 7:00AM CDT
TSX: AMF
Amorfix announces retirement of Meryl Chertoff
CNW Group - Wed Aug 07, 6:00PM CDT
TSX: AMF
Amorfix to provide ALS diagnostic update at the MND/ALS 24th International Symposium
CNW Group - Wed Jul 17, 6:00AM CDT
TSX: AMF
Amorfix provides update on ovarian cancer preclinical studies
CNW Group - Wed Jun 05, 8:29AM CDT
TSX: AMF